143 related articles for article (PubMed ID: 32740565)
1. Occult Breast Carcinoma Is More Common in Women Undergoing Breast Reduction after Contralateral Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick SE; Lam TC
Plast Reconstr Surg; 2020 Aug; 146(2):117e-126e. PubMed ID: 32740565
[TBL] [Abstract][Full Text] [Related]
2. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience.
Colwell AS; Kukreja J; Breuing KH; Lester S; Orgill DP
Plast Reconstr Surg; 2004 Jun; 113(7):1984-8. PubMed ID: 15253187
[TBL] [Abstract][Full Text] [Related]
3. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study.
Ambaye AB; MacLennan SE; Goodwin AJ; Suppan T; Naud S; Weaver DL
Plast Reconstr Surg; 2009 Nov; 124(5):1386-1392. PubMed ID: 20009822
[TBL] [Abstract][Full Text] [Related]
5. Occult carcinoma in 866 reduction mammaplasties: preserving the choice of lumpectomy.
Slezak S; Bluebond-Langner R
Plast Reconstr Surg; 2011 Feb; 127(2):525-530. PubMed ID: 21285757
[TBL] [Abstract][Full Text] [Related]
6. Should we be analysing breast reduction specimens? A systematic analysis of over 1,000 consecutive cases.
Hassan FE; Pacifico MD
Aesthetic Plast Surg; 2012 Oct; 36(5):1105-13. PubMed ID: 22678135
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management.
Brennan ME; Houssami N; Lord S; Macaskill P; Irwig L; Dixon JM; Warren RM; Ciatto S
J Clin Oncol; 2009 Nov; 27(33):5640-9. PubMed ID: 19805685
[TBL] [Abstract][Full Text] [Related]
8. The Management of Breast Cancer Detected by Reduction Mammaplasty.
Carlson GW
Clin Plast Surg; 2016 Apr; 43(2):341-7. PubMed ID: 27012792
[TBL] [Abstract][Full Text] [Related]
9. The Incidence of Occult Malignant and High-Risk Pathologic Findings in Breast Reduction Specimens.
Razavi SA; Hart AM; Betarbet U; Li X; Carlson GW; Losken A
Plast Reconstr Surg; 2021 Oct; 148(4):534e-539e. PubMed ID: 34550926
[TBL] [Abstract][Full Text] [Related]
10. Reduction mammaplasty in patients with history of breast cancer: The incidence of occult cancer and high-risk lesions.
Merkkola-von Schantz PA; Jahkola TA; Krogerus LA; Kauhanen SMC
Breast; 2017 Oct; 35():157-161. PubMed ID: 28753473
[TBL] [Abstract][Full Text] [Related]
11. A Look at the Other Side: High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures for Patients Undergoing Oncoplastic Breast-Conserving Surgery.
Jackson KM; Millen JC; Orozco JIJ; Stern SL; Fancher CE; Grumley JG
Ann Surg Oncol; 2023 Oct; 30(10):6159-6166. PubMed ID: 37535266
[TBL] [Abstract][Full Text] [Related]
12. Should we routinely analyze reduction mammaplasty specimens?
Merkkola-von Schantz PA; Jahkola TA; Krogerus LA; Hukkinen KS; Kauhanen SM
J Plast Reconstr Aesthet Surg; 2017 Feb; 70(2):196-202. PubMed ID: 27908767
[TBL] [Abstract][Full Text] [Related]
13. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients.
Clark CJ; Whang S; Paige KT
Plast Reconstr Surg; 2009 Oct; 124(4):1033-1039. PubMed ID: 19935286
[TBL] [Abstract][Full Text] [Related]
14. [Occult breast cancer discovered following breast reduction].
de Groot RM; Kingma-Vegter F; Bakker XR
Ned Tijdschr Geneeskd; 2009; 153():B314. PubMed ID: 19785796
[TBL] [Abstract][Full Text] [Related]
15. Safety and Effectiveness of Autologous Fat Grafting after Breast Radiotherapy: A Systematic Review and Meta-Analysis.
Chen Y; Li G
Plast Reconstr Surg; 2021 Jan; 147(1):1-10. PubMed ID: 33370043
[TBL] [Abstract][Full Text] [Related]
16. Proliferative Lesions Found at Reduction Mammaplasty: Incidence and Implications in 995 Breast Reductions.
Mastroianni M; Lin A; Hughes K; Colwell AS
Plast Reconstr Surg; 2019 Feb; 143(2):271e-275e. PubMed ID: 30489497
[TBL] [Abstract][Full Text] [Related]
17. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M
Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Fat Grafting on Breast Imaging after Postmastectomy Reconstruction: A Matched Cohort Analysis.
Cason RW; Shammas RL; Broadwater G; Glener AD; Sergesketter AR; Vernon R; Le E; Wickenheisser VA; Marks CE; Orr J; Pyfer BJ; Hollenbeck ST
Plast Reconstr Surg; 2020 Dec; 146(6):1227-1236. PubMed ID: 33234948
[TBL] [Abstract][Full Text] [Related]
19. Occult breast carcinoma in breast reduction specimens in European women.
Goyal A; Coulson SG; Wu JM; Suvarna SK; Reed MW; Caddy CM
Breast Cancer Res Treat; 2011 Aug; 128(3):749-53. PubMed ID: 21625930
[TBL] [Abstract][Full Text] [Related]
20. Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.
Usón Junior PLS; Callegaro Filho D; Bugano DDG; Geyer FC; de Nigro Corpa MV; Gonçalves PDS; Simon SD; Kaliks RA
Pathol Oncol Res; 2018 Jan; 24(1):95-99. PubMed ID: 28391513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
